Correlation Between Acorda Therapeutics and Biofrontera
Can any of the company-specific risk be diversified away by investing in both Acorda Therapeutics and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acorda Therapeutics and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acorda Therapeutics and Biofrontera, you can compare the effects of market volatilities on Acorda Therapeutics and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acorda Therapeutics with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acorda Therapeutics and Biofrontera.
Diversification Opportunities for Acorda Therapeutics and Biofrontera
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acorda and Biofrontera is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Acorda Therapeutics and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and Acorda Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acorda Therapeutics are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of Acorda Therapeutics i.e., Acorda Therapeutics and Biofrontera go up and down completely randomly.
Pair Corralation between Acorda Therapeutics and Biofrontera
If you would invest 1,620 in Acorda Therapeutics on October 8, 2024 and sell it today you would earn a total of 0.00 from holding Acorda Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 5.26% |
Values | Daily Returns |
Acorda Therapeutics vs. Biofrontera
Performance |
Timeline |
Acorda Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biofrontera |
Acorda Therapeutics and Biofrontera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acorda Therapeutics and Biofrontera
The main advantage of trading using opposite Acorda Therapeutics and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acorda Therapeutics position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.Acorda Therapeutics vs. Shionogi Co | Acorda Therapeutics vs. Pacira BioSciences, | Acorda Therapeutics vs. Sunshine Biopharma Warrant | Acorda Therapeutics vs. Biofrontera |
Biofrontera vs. Collegium Pharmaceutical | Biofrontera vs. Phibro Animal Health | Biofrontera vs. ANI Pharmaceuticals | Biofrontera vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |